| Previous Section | Index | Home Page |
17 Mar 2006 : Column 2557W—continued
Electroconvulsive Therapy
Mr. Amess: To ask the Secretary of State for Health how many NHS staff have been investigated for allegedly administering electroconvulsive therapy (a) without obtaining the consent of the individual and (b) having obtained consent by pressure or coercion in each of the last five years for which information is available. [57601]
Ms Rosie Winterton: The information requested is not available centrally.
Geneticists (Waiting Times)
Sandra Gidley: To ask the Secretary of State for Health what assessment she has made of the waiting time for an appointment with a geneticist; and if she will make a statement. [59216]
Ms Rosie Winterton:
The Department does not collect routine data on the waiting time for a first appointment with genetics services.
17 Mar 2006 : Column 2558W
There are practical issues that may contribute to the wait for an appointment with a consultant clinical geneticist. For example, in the case of individuals concerned about their inherited risk of developing breast cancer a detailed investigation of their family history including occurrence and age at onset of any relevant cancers in the family will be required. Verifying this information is necessary before a meaningful first appointment can take place to assess the individual's risk and to decide whether it would be appropriate to offer a genetic test.
Haemodynamic Fluid Optimisation
Mr. Lansley: To ask the Secretary of State for Health(1) what assessment she has made of the (a) cost to the NHS and (b) clinical effects of the use of haemodynamic fluid optimisation; [51889]
(2) what assessment she has made of the (a) cost-effectiveness and (b) clinical-effectiveness of oesophageal doppler monitoring; [57656]
(3) what recent estimate she has made of the level of use of oesophageal doppler monitoring in NHS hospitals in England; whether she plans to increase this level of use; what representations she has received on this matter; what the content of these representations was; and if she will make a statement. [57723]
Ms Rosie Winterton: The National Institute for Health and Clinical Excellence (NICE) is the body charged with appraising new and existing health technologies for use in the national health service. NICE currently has no plans with regard to an appraisal of oesophageal doppler probe haemodynamic optimisation and the Department has no plans to ask it to do so.
The Department has not made an estimate of the use of oesophageal doppler monitoring in NHS hospitals in England and has not received any representations on this matter.
Dr. Gibson: To ask the Secretary of State for Health (1) if she will assess the use of haemodynamic optimisation for patients (a) before, (b) during and (c) after operations; and if she will make a statement; [47830]
(2) if she will assess the potential effect on (a) NHS finance and (b) the numbers of patients treated from using haemodynamic optimisation within the NHS; [47831]
(3) if she will meet the manufacturers of haemodynamic optimisation equipment to discuss its role in the NHS; and if she will make a statement; [47832]
(4) what estimate she has made of the (a) cost and (b) savings to the NHS of standardising the provision of oesophageal Doppler probe haemodynamic optimisation during and post surgery throughout England; and what the cost is per patient of oesophageal Doppler probe haemodynamic optimisation; [53426]
(5) what representations she has received regarding oesophageal Doppler probe haemodynamic optimisation; [53427]
17 Mar 2006 : Column 2559W
(6) what discussions she has had with (a) health service and (b) funding managers regarding the introduction of oesophageal Doppler probe haemodynamic optimisation during and post surgery; [53428]
(7) if she will introduce oesophageal Doppler probe haemodynamic optimisation as a standard treatment during and post surgery throughout the NHS. [53429]
Ms Rosie Winterton: The National Institute for Health and Clinical Excellence (NICE) is the body charged with appraising new and existing health technologies for use in the national health service. NICE currently has no plans with regard to an appraisal of oesophageal Doppler probe haemodynamic optimisation and the Department has no plans to ask it to do so.
The Department has not received any representations regarding oesophageal doppler probe haemodynamic optimisation and there are no plans to meet with the manufacturers of oesophageal doppler probe haemodynamic optimisation equipment to discuss its role in the NHS.
The Department has not had any discussions with the NHS and funding managers regarding the introduction of oesophageal Doppler probe haemodynamic optimisation during and post surgery, and no estimates of costs or the number of patients treated have been made.
Health Care (Tamworth)
Mr. Jenkins: To ask the Secretary of State for Health what grants have been provided to help patients accessing sexual health services in Tamworth. [53405]
Ms Rosie Winterton: Primary care trusts (PCTs) are responsible for delivering sexual health services to their local populations and resource this from their baselines allocations. In February 2005, individual PCTs, including those covering the Tamworth area were notified of their additional choosing health revenue allocation for sexual health. In 2006–07, an extra £91.5 million will be allocated to PCTs for sexual health modernisation which includes funding for chlamydia screening, genito-urinary medicine and reproductive health. A further £111.5 million will be allocated in 2007–08. Also, an extra £15 million for capital was allocated this financial year for sexual health services and a further £25 million allocated in 2006–07.
Data on spend on sexual health services in each PCT is not collected centrally.
Health Education
Anne Milton: To ask the Secretary of State for Health what assessment the Government has made of the effectiveness of educating the public on health issues through media campaigns (a) on television, (b) in newspapers and magazines, (c) on billboards and (d) on radio. [50566]
Mr. Byrne:
The Department utilises a range of media across different campaigns. Our media schedules are developed following consideration of our audience, and the appropriate means of reaching. For example, national television and press are appropriate for mass
17 Mar 2006 : Column 2560W
public awareness. We assess the contribution of different media, but our evaluation of any given campaign will look at the totality of media deployed.
Herceptin
Mr. Lansley: To ask the Secretary of State for Health whether she has instructed primary care trusts that they should have regard to the UK Clinical Guidelines on the use of Adjuvant Trastuzumab (Herceptin) with or following chemotherapy in HER-2 positive early stage breast cancer published by the National Cancer Research Institute in deciding whether they should make Herceptin available to patients. [59664]
Ms Rosie Winterton: Primary care trusts have not been instructed to have regard to the National Cancer Research Institute guidelines. However, they have been alerted to them. A short article was included in NHS chief executive's Bulletin: Issue 300, circulated on 13 January 2006. This stated that:
The National Cancer Research Institute has produced a UK Clinical Guideline on the use of Herceptin for early breast cancer. This provides useful information to those considering prescribing Herceptin for this indication in advance of a decision on licensing and the publication of NICE guidance."
A link to the guideline was also provided.
Hospital Admissions (Alcohol-related)
Mr. Stewart Jackson: To ask the Secretary of State for Health how many admissions to hospital with an alcohol-related diagnosis via accident and emergency departments there were in the (a) Norfolk, Suffolk and Cambridgeshire Health Authority area and (b) Peterborough and Stamford Hospitals NHS Foundation Trust area in each year between 1997 and 2005. [57193]
Ms Rosie Winterton: The information requested is shown in the tables.
Notes:
1.Alcohol related diseases defined as following ICD-10 codes recorded in primary diagnosis:
F10: Mental and behavioural disorders due to use of alcohol
K70: Alcoholic liver disease
T51: Toxic effect of alcohol
2.Selected methods of admission:
Emergency (via accident and emergency (A&E) services including the casualty department of the provider) Emergency (other means, including patients who arrive via A&E department of another health care provider)
17 Mar 2006 : Column 2561W
(7)Alcohol related diseases defined as following ICD-10 codes recorded in primary diagnosis:
F10: Mental and behavioural disorders due to use of alcohol
K70: Alcoholic liver disease
T51: Toxic effect of alcohol
(8)Selected methods of admission:
Emergency (via A&E services including the casualty department of the provider)
Emergency (other means, including patients who arrive via A&E department of another health care provider)
Notes (general):
Finished admission episodes
A finished admission episode is the first period of in-patient care under one consultant within one health care provider. Admissions do not represent the number of in-patients, as a person may have more than one admission within the year.
Diagnosis (primary diagnosis)
The primary diagnosis is the first of up to 14 (seven prior to 2002–03) diagnosis fields in the hospital episodes statistics (HES) data set and provides the main reason why the patient was in hospital.
Ungrossed data
Figures have not been adjusted for shortfalls in data, that is, the data is ungrossed.
Primary care trust (PCT) and strategic health authority (SHA) data quality
PCT and SHA data was added to historic data years in the HES database using 2002–03 boundaries, as a one-off exercise in 2004. The quality of data on PCT of treatment and SHA of treatment is poor in 1996–97, 1997–98 and 1998–99, with over a third of all finished episodes having missing values in these years. Data quality of PCT and general practitioner (GP) practices and SHA of GP practice in 1997–98 and 1998–99 is also poor, with a high proportion missing values where practices changed or ceased to exist. There is less change in completeness of the residence-based fields over time, where the majority of unknown values are due to missing postcodes on birth episodes. Users of time series analysis including these years need to be aware of these issues in their interpretation of the data.
| Next Section | Index | Home Page |